| Miss Leah Denny, OTR/L | |
|
14809 North St, Adams Center, NY 13606-2231 | |
| (315) 408-9301 | |
| Not Available |
| Full Name | Miss Leah Denny |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Physical Rehabilitation |
| Location | 14809 North St, Adams Center, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962087239 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0019X | Occupational Therapist - Physical Rehabilitation | 023897 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Leah Denny, OTR/L 14809 North St, Adams Center, NY 13606-2231 Ph: (315) 408-9301 | Miss Leah Denny, OTR/L 14809 North St, Adams Center, NY 13606-2231 Ph: (315) 408-9301 |
News Archive
Only half of the men who receive a prostate cancer diagnosis in North Carolina consult with more than one type of physician before deciding on a course of treatment, according to research presented by University of North Carolina researchers at the 2013 American Society for Radiation Oncology annual meeting on Sept. 24.
A new study reports that a head-to-head comparison of the efficacy of the three vaccines used in the USA indicates substantial protection against hospitalization with COVID-19 following vaccination with any of these vaccines.
On January 31, 2015, the National Comprehensive Cancer Network celebrates its 20th anniversary. Originally announced as an alliance of 13 leading cancer centers in 1995, NCCN has grown to a network of 25 academic cancer centers; the NCCN mission as an alliance of leading academic cancer centers devoted to patient care, research, and education, is to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
› Verified 1 days ago
Miss Rachel Elise Fish, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 13180 Us Route 11, Adams Center, NY 13606 Phone: 315-955-5237 |